Correlation Between Emergent Biosolutions and Minerva Neurosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Minerva Neurosciences, you can compare the effects of market volatilities on Emergent Biosolutions and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Minerva Neurosciences.

Diversification Opportunities for Emergent Biosolutions and Minerva Neurosciences

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Emergent and Minerva is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Minerva Neurosciences go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Minerva Neurosciences

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 1.84 times more return on investment than Minerva Neurosciences. However, Emergent Biosolutions is 1.84 times more volatile than Minerva Neurosciences. It trades about 0.1 of its potential returns per unit of risk. Minerva Neurosciences is currently generating about -0.03 per unit of risk. If you would invest  242.00  in Emergent Biosolutions on September 2, 2024 and sell it today you would earn a total of  770.00  from holding Emergent Biosolutions or generate 318.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Emergent Biosolutions  vs.  Minerva Neurosciences

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.
Minerva Neurosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Minerva Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Emergent Biosolutions and Minerva Neurosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and Minerva Neurosciences

The main advantage of trading using opposite Emergent Biosolutions and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.
The idea behind Emergent Biosolutions and Minerva Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
FinTech Suite
Use AI to screen and filter profitable investment opportunities